Study of HER2 Expression and its Relation to Tumor Characteristics among Gastric Adenocarcinoma Patients of Firoozgar Hospital, Tehran, Iran; in 2010 and 2011
Background: One million people are diagnosed with gastric cancer (GC) annually and the prognosis for patients with advanced GC or gastroesophageal junction (GEJ) cancer is usually poor with a median survival time of 8 to 10 months. Recent reports have identified that anti HER2 target therapy improve...
Main Authors: | Ali Basi, Atefeh Raoofi, Hamed Vaseghi, Ali Zare-Mehrjardi |
---|---|
Format: | Article |
Language: | English |
Published: |
Tehran University of Medical Sciences
2015-10-01
|
Series: | International Journal of Hematology-Oncology and Stem Cell Research |
Subjects: | |
Online Access: | https://ijhoscr.tums.ac.ir/index.php/ijhoscr/article/view/358 |
Similar Items
-
Study of HER2 Expression and its Relation to Tumor Characteristics among Gastric Adenocarcinoma Patients of Firoozgar Hospital, Tehran, Iran; in 2010 and 2011
by: Ali Basi, et al.
Published: (2012-10-01) -
Expression of Her2-Neu in Primary Gastric and Gastroesophageal Adenocarcinoma: An Experience from a Tertiary Center in South India
by: Aditi Damle, et al. -
Targeted and Immunotherapy Approaches in HER2-Positive Gastric and Gastroesophageal Junction Adenocarcinoma: A New Era
by: Maluki Radford, et al.
Published: (2023-08-01) -
Sexual Difference Matters: Females with High Microsatellite Instability Show Increased Survival after Neoadjuvant Chemotherapy in Gastric Cancer
by: Meike Kohlruss, et al.
Published: (2021-03-01) -
Evaluation of second-line apatinib plus irinotecan as a treatment for advanced gastric adenocarcinoma or gastroesophageal conjunction adenocarcinoma: a prospective, multicenter phase II trial
by: Jinglei Qu, et al.
Published: (2023-04-01)